0
Your cart

Your cart is empty

Books > Medicine > Other branches of medicine > Pathology > Medical microbiology & virology

Buy Now

Antiviral Agents - Advances and Problems (Paperback, 2001 ed.) Loot Price: R1,681
Discovery Miles 16 810
Antiviral Agents - Advances and Problems (Paperback, 2001 ed.): S. Ren, E.J. Lien, N.A Roberts, Q.-M. Wang, B.A. Heinz, K.A....

Antiviral Agents - Advances and Problems (Paperback, 2001 ed.)

S. Ren, E.J. Lien, N.A Roberts, Q.-M. Wang, B.A. Heinz, K.A. Staschke, J. M. Colacino, E.C. Villareal; Edited by Ernst M. Jucker

Series: Progress in Drug Research, 002

 (sign in to rate)
Loot Price R1,681 Discovery Miles 16 810 | Repayment Terms: R158 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Donate to Gift Of The Givers

In the treatment of infections caused by rapidly mutating viruses like human immunodeficiency virus (HIV), combination therapy with multiple drugs act ing by different mechanisms offers several advantages over monotherapy. It may provide: synergistic effect, possible reduction of dosages and side-effects, and reduction of the chance of drug resistance. In the past few years, hun dreds of HIV protease inhibitors have been synthesized and tested in order to overcome the limitations of reverse transcriptase inhibitors like zidovudine and others. In this review, emphasis is placed on the development of HIV pro tease inhibitors as antiviral agents against HIY, and structure-activity rela tionship analysis of saquinavir and related compounds. Limitations of some protease inhibitors and ways to overcome the shortcomings are presented. Among these many protease inhibitors five have been marketed during 1995-1999. They are saquinavir, ritonavir, indinavir, nelfinavir and ampre navir. Their different structural features, important physicochemical, phar macokinetic and clinical profiles are presented in a table form for easy com parison. It is hoped that in the future new drugs based on additional mech anisms can be developed for the treatment of AIDS. Contents 4 1 Introduction .................................................................... . HIV protease as a target for chemotherapy ................................... . 2 5 Design of protease inhibitors .................................................. . 3 5 Basis of rational design of HIV protease inhibitors ........................... . 3.1 5 New development of HIV protease inhibitors ................................ . 6 3.2 HIV protease inhibitors on the market ........................................ . 20 4 20 4.1 SAR of saquinavir and related compounds .................................... ."

General

Imprint: Birkhauser Verlag AG
Country of origin: Switzerland
Series: Progress in Drug Research, 002
Release date: June 2001
First published: 2001
Contributors: S. Ren • E.J. Lien • N.A Roberts • Q.-M. Wang • B.A. Heinz • K.A. Staschke • J. M. Colacino • E.C. Villareal
Editors: Ernst M. Jucker
Dimensions: 244 x 170 x 15mm (L x W x T)
Format: Paperback
Pages: 258
Edition: 2001 ed.
ISBN-13: 978-3-7643-6547-9
Categories: Books > Medicine > Other branches of medicine > Pathology > Medical microbiology & virology
Books > Medicine > Other branches of medicine > Pharmacology > General
LSN: 3-7643-6547-1
Barcode: 9783764365479

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners